VBIO ▲ +8.4% - Valion Bio, Inc.
$VBIO - Valion Appoints Life Sciences Veteran Dean Zikria as Interim CEO and Announces Board Leadership Transitions
Valion Bio rose 8.4% following the appointment of life sciences veteran Dean Zikria as interim CEO and related board leadership changes. The executive transition appeared to signal investor confidence in the company's strategic direction under new leadership.
23-SEP-2026 08:00 AM ET
Share this post
More filings for $VBIO
VBIO ▲ +4.8% - Valion Bio, Inc.Oct 30, 2026VBIO ▼ -1.3% - Valion Bio, Inc.Oct 28, 2026VBIO ▲ +18.9% - Valion Bio, Inc.Oct 26, 2026VBIO ▲ +4.1% - Valion Bio, Inc.Oct 21, 2026VBIO ▼ -9.7% - Valion Bio, Inc.Oct 15, 2026VBIO ▲ +39.3% - Valion Bio, Inc.Oct 15, 2026
View full $VBIO filing history →💬 Comments
Loading comments…
Leave a comment